Summary: In Rolling Stone, the co-founders of DoubleBlind consider the prospect of federal drug policy changes surrounding psychedelics under President Joe Biden and a new Congress. MAPS Director of Policy and Advocacy Natalie Ginsberg, M.S.W., says that ending the war on drugs is not “unreasonable to hold as a goal that we’re moving towards, especially because so many states are starting to revisit their approach to drug criminalization.”
Originally appearing here.
